The Journal of Neuroscience, August 20, 2003, 23(20):7479-7488
Previous Article | Next Article 
Activity-Dependent Autocrine-Paracrine Activation of Neuronal P2Y Receptors
Eugenia Moskvina,
Ursula Unterberger, and
Stefan Boehm
Institute of Pharmacology, University of Vienna, A-1090 Vienna,
Austria
 |
Abstract
|
|---|
Activation of P2Y receptors by released nucleotides subserves important
autocrine-paracrine functions in various non-neural tissues. To investigate
how P2Y receptors are activated in a neuronal environment, we used PC12 cells
in which nucleotides were found to elicit increases in inositol phosphates via
P2Y2 and decreases in cAMP via P2Y12 receptors.
Depolarization of PC12 cells raised inositol phosphates, and blockade of
voltage-gated Ca2+ channels by
Cd2+ or degradation of extracellular nucleotides by
apyrase prevented this effect. In nondepolarized cells, apyrase did not affect
inositol phosphates. Depolarization of PC12 cells also reduced the
A2A receptor-mediated synthesis of cAMP. This effect was again
prevented by Cd2+ or apyrase, but apyrase enhanced the
synthesis of cAMP even in nondepolarized cells. Overexpression of rat
P2Y2 receptors increased the nucleotide-dependent inositol
phosphate accumulation and enhanced the effect of K+
depolarization. Nevertheless, apyrase still failed to alter spontaneous
inositol phosphate accumulation. Expression of rat P2Y1 receptors,
in contrast, led to huge increases in spontaneous inositol phosphate
accumulation, which was reduced by a receptor antagonist or by apyrase. This
increased synthesis of inositol phosphates could not be further enhanced by
depolarization or receptor agonists, but when endogenous nucleotides were
removed by superfusion, recombinant P2Y1 receptors could be
activated to mediate an inhibition of M-type K+ channels. These
results indicate that nucleoside diphosphate-sensitive (P2Y12 and
P2Y1) receptors are activated by spontaneous nucleotide release,
whereas triphosphate-sensitive (P2Y2) receptors require an excess
of depolarization-evoked release to become activated.
Key words: P2Y receptors; inositol phosphates; cAMP; M-type K+ current; PC12 cells; nucleotide release
 |
Introduction
|
|---|
Extracellular nucleotides regulate various physiological functions,
including smooth muscle contraction, platelet aggregation, mucociliary
clearance, cell proliferation, and neurotransmission. These actions are
mediated by ionotropic P2X and G-protein-coupled P2Y receptors
(Ralevic and Burnstock, 1998
).
At least seven different mammalian P2Y receptors have been identified:
P2Y1 (Tokuyama et al.,
1995
), P2Y12
(Hollopeter et al., 2001
), and
P2Y13 (Communi et al.,
2001
) are preferentially activated by ADP, whereas P2Y6
is activated by UDP (Nicholas et al.,
1996
). P2Y11 prefers ATP as an agonist
(Communi et al., 1997
), whereas
P2Y2 (Lustig et al.,
1993
) and P2Y4
(Communi et al., 1995
;
Kennedy et al., 2000
) are
equally sensitive to ATP and UTP. In rats, P2Y1, P2Y2,
P2Y4, P2Y6, and P2Y12 have been detected
(Ralevic and Burnstock, 1998
;
Hollopeter et al., 2001
). All
P2Y receptors of the rat but P2Y12 mediate increases in inositol
phosphates (IPs) (Ralevic and Burnstock,
1998
), and P2Y12 mediates an inhibition of adenylyl
cyclase (Hollopeter et al.,
2001
).
ATP is released from various cells including fibroblast-like, epithelial,
endothelial, glial, and neuronal cells
(von Kugelgen et al., 1994
;
Schlosser et al., 1996
;
Wang et al., 1996
;
Lazarowski et al., 2000
;
Ostrom et al., 2000
). ATP
release from non-neural cells is Ca2+ independent and
can be elicited by different stimuli such as hypotonic solutions
(Wang et al., 1996
),
mechanical stimulation (Schlosser et al.,
1996
), or exchange of culture media
(Lazarowski et al., 2000
;
Ostrom et al., 2000
). In
neurons, ATP is stored in vesicles and thus released by exocytosis
(Zimmermann, 1994
). Vesicle
exocytosis occurs spontaneously at a slow rate and is accelerated when
transmembrane Ca2+ entry is triggered by
depolarization-induced opening of voltage-gated Ca2+
channels (Matthews, 1996
).
Therefore, neuronal ATP release is depolarization and
Ca2+ dependent (von
Kugelgen et al., 1994
).
In non-neural tissues, such as liver, kidney, bones, and blood vessels,
released nucleotides subserve autocrine-paracrine functions by activating
certain P2Y receptors (Gerasimovskaya et
al., 2002
; Junankar et al.,
2002
; Schwiebert et al.,
2002
; Torres et al.,
2002
; You et al.,
2002
). In neurons, action potential- and
Ca2+-dependent release of ATP contributes to synaptic
transmission via P2X receptors (Robertson
et al., 2001
); however, much less is known about the activation of
neuronal P2Y receptors by released nucleotides. One known example is the
ATP-mediated autocrine inhibition of voltage-gated Ca2+
channels in bovine chromaffin cells, but the P2Y receptor that was involved
remained unknown (Currie and Fox,
1996
). To investigate how different P2Y receptors are activated by
nucleotides released from neuronal sources, we used PC12 cells. These rat
phaeochromocytoma cells are ontogenetically related to sympathetic neurons and
release transmitters in an exocytotic manner
(Greene and Tischler, 1976
;
Fisher and Burgoyne, 1999
).
Aside from P2X1 through P2X6, PC12 cells express RNA for
P2Y2, P2Y4, P2Y6, and P2Y12
receptors (Arslan et al.,
2000
). Taking the synthesis of IPs and the reduction of cAMP
accumulation as measures of receptor activation, we show that neuronal P2Y
receptors are activated in an autocrine-paracrine manner as described
previously for non-neural cells. However, diphosphate- and
triphosphate-sensitive receptors are differentially activated by spontaneous
and depolarization-evoked nucleotide release.
 |
Materials and Methods
|
|---|
Materials. [2,8-3H]adenine (specific activity 32
Ci/mmol) and myo-[3H]inositol (74.7 Ci/mmol) were obtained from NEN
(Vienna, Austria). Na-UTP, Na-UDP, Na2-ATP, Na-ADP,
4-(3-butoxy-4-methoxybenzyl) imidazoline-2-one (RO 20-1724),
3',5'-cAMP, suramin, apyrase (grade VII, with an
1:1 ratio in
ATPase and ADPase activity), 2-methylthio-AMP, 2-methylthio-ATP,
pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid tetrasodium
(PPADS), and
2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido-adenosine
(CGS 21680) were purchased from Sigma (Vienna, Austria).
2-Chloro-N6-methyldeoxyadenosine
3',5'-biphosphate (MRS 2216) was a gift of Dr. K. A. Jacobson
(National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda,
MD).
Cell culture and transfection methods. PC12 cells were obtained
from the European Collection of Animal Cell Cultures (Salisbury, UK), plated
onto collagen-coated (Biomedical Technologies, Stoughton, MA) six-well culture
dishes (NUNC, Roskilde, Denmark), and kept in OptiMEM (Invitrogen, Vienna,
Austria) supplemented with 0.2 mM L-glutamine (HyClone, Aalst,
Belgium), 25,000 IU/l-1 penicillin and 25
mg/l-1 streptomycin (Sigma, Vienna, Austria), 5% fetal
calf serum, and 10% horse serum (both from Invitrogen). Once per week, cell
cultures were split, and the medium was exchanged twice per week.
For the generation of PC12 cell clones stably expressing either the rat
P2Y1 receptor linked to the green fluorescent protein
(P2Y1-GFP) or the rat P2Y2 receptor, 15 µg of a rat
P2Y1-enhanced GFP expression vector (kindly provided by Dr. G.
Reiser, Magdeburg, Germany) (Vohringer et
al., 2000
) or 15 µg of the expression vector pcDNA3 containing
the coding sequence for the rat P2Y2 receptor (kindly provided by
Dr. T. Webb, Leicester, UK) was mixed with 50 µl of the TransFast
transfection reagent (Promega, Mannheim, Germany) and added to semiconfluent
PC12 cell cultures in serum-free medium. After a 1 hr incubation at 37°C,
2 vol of serum-free medium and the appropriate amount of serum (as above) were
added. Forty-eight hours after transfection, this medium was exchanged for a
medium supplemented with 500 µg/ml neomycin (G418) to allow for selection
of drug resistance. This selection medium was replaced every 3-4 d until
distinct islands of surviving cells were visible. Individual clones of
antibiotic-resistant cells were transferred to 24-well plates and grown in
medium containing 200 µg/ml neomycin.
Northern blot analysis. Northern blots were performed as described
previously for P2Y receptors expressed in primary cultures of sympathetic
neurons (Vartian et al.,
2001
). After extraction from PC12 cell cultures, 30 µg of RNA
per lane was separated by electrophoresis through formaldehyde containing 1.5%
agarose gels and transferred to nylon membranes. Subsequent to UV
cross-linkage, membranes were hybridized overnight at 65°C in a
hybridization solution containing 50 mM PIPES, pH 6.5, 100
mM NaCl, 50 mM sodium phosphate buffer, pH 7.0, 1
mM EDTA, pH 8.0, and 5% SDS. After hybridization, the blots were
washed twice in 5% SDS, 1x SSC at 65°C for 15 min, and finally
exposed to x-ray films. Thereafter, probes were removed from the membranes,
and blots were subjected to further hybridization with additional P2Y
receptor-specific probes.
Cloned fragments of P2Y1, P2Y2, P2Y4, and
P2Y6 were used as probes for hybridization. The corresponding PCR
fragments were amplified from cDNA obtained by reverse transcription of total
RNA isolated from rat sympathetic neurons as described
(Vartian et al., 2001
). The
PCR fragments were separated by electrophoresis through a 2% agarose gel,
isolated, and cloned into pCR3.1 vector (Invitrogen). Plasmid DNA was isolated
from positive clones and sequenced to verify the P2Y receptor identity.
EcoRI fragments carrying the P2Y receptor sequences were labeled with
[
-32P]deoxycytidine triphosphate by random priming using the
Prime-a-Gene labeling system (Promega).
Determination of inositol phosphates. The method for determining
IPs was adapted from that used previously for primary neuronal cell cultures
(Bofill-Cardona et al., 2000
)
as follows. Cells were grown to confluence and incubated in serum-free and
inositol-free DMEM supplemented with myo-[3H]inositol (2.5
µCi/ml) for 48 hr. Thereafter, the medium was exchanged for OptiMEM
supplemented with 10 mM LiCl for 20 min to block inositol
monophosphatase (Phiel and Klein,
2001
). Antagonists or apyrase (1 U/ml) were added together with
LiCl when appropriate. Subsequently, the cells were incubated for an
additional 30 min (unless indicated otherwise) in a buffer (120 mM
NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM
CaCl2, 20 mM glucose, 10 mM HEPES, 10
mM LiCl, adjusted to pH 7.4 with NaOH) containing one or more of
the following: agonists, antagonists, apyrase, CdCl2 (1
mM), and/or 100 mM KCl (NaCl was reduced accordingly).
Finally, cells were lysed in boiling EDTA (10 mM) solution. After
centrifugation of samples, an aliquot of the supernatant was removed to
estimate the total water-soluble radioactivity. The remainder was applied to
anion exchange chromatography columns (Dowex AG 1-X8; Bio-Rad, Vienna,
Austria) and washed three times with 3 ml of H2O. Columns were then
washed with 10 ml of 50 mM ammonium formate, and finally inositol
monophosphate (IP1) was eluted with 6 ml of 0.18 M
ammonium formate and 0.1 M formic acid and quantitated by liquid
scintillation counting (Bofill-Cardona et
al., 2000
). In some experiments, the radioactivity remaining in
the pellet was also determined.
The radioactivity in the fraction of IP1 was expressed as
percentage of the water-soluble radioactivity in the cells, which consists
mainly of inositol (Bofill-Cardona et al.,
2000
). In initial experiments, the radioactivity in the
IP1 fraction was also calculated as percentage of the radioactivity
in the pellet; however, these values displayed large variations between
experiments (see Fig. 1
A) and thus were not used routinely. Nucleotides or
bradykinin (1 µM) reproducibly caused time-dependent increases
in IP1 when compared with the values obtained in their absence (see
Fig. 1 A).
Nevertheless, the extent of basal and agonist-induced IP1
accumulation may vary between different preparations. Therefore, the
IP1 values obtained after a 30 min incubation in the presence of
nucleotides, bradykinin, apyrase, CdCl2, and KCl, respectively,
were normalized to the values obtained after a 30 min incubation in their
absence within the same preparation (normalized to basal).

View larger version (17K):
[in this window]
[in a new window]
|
Figure 1. Enhancement of IP accumulation by nucleotides and bradykinin. A,
After loading with myo-[3H]inositol, PC12 cells were preincubated
in LiCl (10 mM) for 20 min. During subsequent incubation periods
(5-45 min), LiCl alone (basal; ), LiCl plus UTP (10 µM;
), or LiCl plus bradykinin (1 µM; ) were present. The
amount of radioactivity retrieved within the fraction of inositol
monophosphate (IP1) after these incubation periods is shown as
counts per minute (cpm; top panel), as percentage of the total radioactivity
in the pellet (% pellet; middle panel), or as percentage of the total
water-soluble radioactivity extracted from the cell cultures (% soluble;
bottom panel). The results stem from two independent experiments, each
performed in triplicate (i.e., n = 6). B, After loading with
myo-[3H]inositol and preincubation in LiCl (10 mM), the
cells were incubated for 30 min in LiCl alone or in LiCl plus the indicated
concentrations of nucleotides. The amount of radioactivity retrieved within
the fraction of inositol monophosphate (IP1) was calculated as
percentage of the total water-soluble radioactivity extracted from the cell
cultures, and values obtained in the presence of nucleotides were normalized
to the data obtained in their absence (normalized to basal). In the absence of
nucleotides, 3822.9 ± 222.0 cpm were retrieved in the IP1
fraction (n = 36).
|
|
Determination of cAMP. The accumulation of cAMP in PC12 cell
cultures was determined as described previously
(Unterberger et al., 2002
).
After labeling of cellular purines with tritiated adenine (2.5 µCi/ml for
12 hr), the medium was replaced by the buffer described above supplemented
with 100 µM of the phosphodiesterase inhibitor RO 20-1724 and 1
U/ml adenosine deaminase. Dishes were then kept at room temperature for 105
min. During the last 15 min of this incubation period, the adenosine
A2A receptor agonist CGS 21680, ADP (10 µM), apyrase
(1 U/ml), CdCl2 (1 mM) and 100 mM KCl (NaCl
was reduced accordingly) were also included in the medium. Where indicated,
the P2Y12 receptor antagonist 2MesAMP
(Hollopeter et al., 2001
) was
present for the last 25 min. The incubation was terminated by exchanging the
buffer for 1 ml of 2.5% perchloric acid containing 100 µM
nonlabeled cAMP followed by a 20 min incubation at 4°C. Subsequently, cAMP
was separated from the other purines by a chromatographic procedure described
previously (Unterberger et al.,
2002
). Finally, radioactivity within the samples obtained was
determined by liquid scintillation counting.
The radioactivity in the fraction of cAMP was expressed as percentage of
the total radioactivity extracted from the cells. Stimulation of PC12 cells
with the adenosine A2A receptor agonist CGS 21680 caused a
reproducible increase in these values of cAMP, but the extent of basal and
stimulated cAMP synthesis may vary between different preparations
(Unterberger et al., 2002
).
Therefore, the values of cAMP obtained in the presence of CGS 21680 were
normalized to the values obtained in its absence within the same preparation
(normalized to basal).
Electrophysiology. Currents through M-type K+
(KM) channels were determined as described previously for
primary neuronal cell cultures (Scholze et
al., 2002
). Experiments were performed at room temperature
(20-24°C) on isolated PC12 cells using the perforated-patch modification
of the patch-clamp technique, which prevents rundown of M currents
(IM). Patch pipettes were pulled (Flaming-Brown puller,
Sutter Instruments, Novato, CA) from borosilicate glass capillaries (Science
Products, Frankfurt/Main, Germany) and front-filled with a solution consisting
of (in mM): 75 K2SO4, 55 KCl, 8
MgCl2, and 10 HEPES, adjusted to pH 7.3 with KOH. Then, electrodes
were back-filled with the same solution containing 200 µg/ml amphotericin B
(in 0.8% DMSO), which yielded tip resistencies of 1-3 M
. PC12 cells
were submerged in and continuously superfused with (in mM): 140
NaCl, 6.0 KCl, 2.0 CaCl2, 2.0 MgCl2, 20 glucose, 10
HEPES, adjusted to pH 7.4 with NaOH. Tetrodotoxin (0.5 µM) was
included to suppress voltage-activated Na+ currents. Superfusion
was performed by the use of a DAD-12 drug application device (Adams &
List, Westbury, NY). IM relaxations were evoked once every
20 sec by 1 sec hyperpolarizing voltage steps from -30 to -55 mV; the
difference between current amplitudes 20 msec after the onset of
hyperpolarizations and 20 msec before re-depolarization was taken as a measure
for IM. Amplitudes obtained during the application of ADP
(b) were compared with those measured before (a) and after
(c) application of the nucleotide by calculating 100 -
(200b/[a + c]) = % inhibition
(Scholze et al., 2002
).
Statistics. All data represent arithmetic means ± SEM;
n represents number of culture dishes or of single cells in
electrophysiological experiments. If error bars are not shown in Figures, they
were smaller than the symbols. Concentration-response curves were fitted to
experimentally obtained data by the ALLFIT program
(De Lean et al., 1978
).
Significances of differences between single data points were evaluated by the
nonparametric Mann-Whitney test, and p values <0.05 were accepted
as indicators of statistically significant differences.
 |
Results
|
|---|
Activation of endogenous P2Y2 receptors by added
nucleotides
In nondifferentiated PC12 cells, ATP and UTP have been found either to
stimulate an accumulation of IPs (Murrin
and Boarder, 1992
) or to leave IP3 unchanged
(Arslan et al., 2000
). To
verify whether the present PC12 cell clone was capable of synthesizing IPs in
response to nucleotides, PC12 cells were labeled with tritiated myo-inositol
and preincubated in 10 mM LiCl for 20 min to block inositol
phosphatases. Thereafter, the cells were incubated for various periods of time
in 10 µM UTP, in 1 µM bradykinin for comparison,
or in buffer lacking agonists. As shown in
Figure 1A, both UTP
and bradykinin caused time-dependent increases in the radioactivity retrieved
in the fraction of IP1, which hardly changed in the absence of
agonists.
When UTP was applied for 30 min at different concentrations, its effect was
concentration-dependent, with half-maximal stimulation between 1 and 10
µM. At concentrations up to 100 µM, ATP was
equi-effective to UTP in stimulating IP1 synthesis, but at higher
concentrations, ATP was much more effective than UTP. In contrast, ADP, UDP,
and 2MeSATP at up to 100 µM did not cause significant changes in
IP1 accumulation (Fig.
1B).
To further elucidate which P2 receptors mediated these effects, two P2
receptor antagonists, suramin and PPADS, were used. Suramin, at 10-100
µM, reduced the IP1 stimulating effect of 10
µM UTP in a concentration-dependent manner, whereas PPADS (100
µM) had no such effect. PPADS also failed to attenuate the
effect of 10 µM ATP (Fig.
2A) but reduced the effect of 1 mM ATP; in its
presence, ATP was equipotent and equi-effective to UTP applied alone in
stimulating IP1 synthesis: half-maximal effects occurred at 3.2
± 1.2 µM UTP and at 4.7 ± 1.7 µM ATP
(plus 100 µM PPADS), and the maximum with both nucleotides was a
2.5-fold stimulation over basal (Fig.
2B). PPADS (100 µM) entirely blocks P2X
receptor-mediated events in PC12 cells
(Vartian and Boehm, 2001
).
Therefore, these results suggest that ATP concentrations above 100
µM enhance IP1 accumulation via activation of both
P2Y and P2X receptors. UTP, in contrast, does not activate P2X receptors
(Ralevic and Burnstock, 1998
)
and thus stimulated IP1 synthesis only via P2Y receptors. Among the
P2Y receptors expressed in the rat, P2Y2 and P2Y4
receptors are activated by both ATP and UTP
(Kennedy et al., 2000
).
Previously, rat P2Y4 receptors were found to be blocked by PPADS
(Suarez-Huerta et al., 2001
)
but not by suramin (Bogdanov et al.,
1998
), exactly the opposite of the present findings. Therefore,
the present results are compatible with P2Y2 receptors mediating
the nucleotide-dependent IP synthesis.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 2. Characterization of the receptor mediating the nucleotide-dependent
synthesis of IPs. After loading with myo-[3H]inositol and
preincubation in LiCl (10 mM), the cells were incubated for 30 min
in LiCl alone or in LiCl plus nucleotides. The amount of radioactivity
retrieved within the fraction of inositol monophosphate (IP1) was
calculated as percentage of the total water-soluble radioactivity extracted
from the cell cultures, and values obtained in the presence of nucleotides
were normalized to the data obtained in their absence (normalized to basal).
A, Cultures were exposed to the indicated concentrations of either
UTP (open bars) or ATP (filled bars) in the absence or presence of the
indicated concentrations of suramin or PPADS. n = 6-9.
*p < 0.05 and ***p < 0.001
versus the value obtained in the presence of UTP only; n.s. indicates no
significant difference. In the absence of nucleotides or antagonists, 3580.3
± 363.4 cpm were retrieved in the IP1 fraction (n =
9). B, Cultures were exposed to the indicated concentrations of
either UTP alone or ATP plus 100 µM PPADS. n = 4-9. In
the absence of nucleotides or antagonists, 3023.8 ± 311.5 cpm were
retrieved in the IP1 fraction (n = 16). C,
Northern blot analysis performed with total RNA (30 µg per lane) isolated
from either PC12 cell cultures or from rat superior cervical ganglion (SCG)
cultures. PC12 cells had been treated with nerve growth factor (+NGF) (50
ng/ml for 5 d) before RNA extraction or remained untreated (-NGF). The blot
was probed consecutively with [ 32P]deoxycytidine
triphosphate-labeled cDNA probes specific for P2Y1,
P2Y2, P2Y4, and P2Y6, among which the
P2Y4-specific probe gave no signal (data not shown). The bottom
panel shows total RNA stained with methylene blue. D, PC12 cells had
been treated with nerve growth factor (+NGF) (50 ng/ml for 5 d) or remained
untreated (-NGF). The cultures were then exposed to the indicated
concentrations of UDP (squares) or UTP (circles). n = 3-9.
*p < 0.05 and ***p < 0.01 versus
the value obtained in cells not treated with nerve growth factor. In the
absence of nucleotides, 2929.7 ± 332.6 cpm were retrieved in the
IP1 fraction of NGF-treated cells (n = 7), and 3784.3
± 264.8 cpm were retrieved in the IP1 fraction of untreated
cells (n = 7; p = 0.12 vs NGF-treated cells).
|
|
To investigate in further detail which P2Y receptor subtypes might be
involved in the nucleotide-dependent synthesis of IP1 as described
above, we performed Northern blots to check for their expression level. Total
RNA was isolated from either untreated or NGF-differentiated PC12 cells and
compared with RNA from primary cultures of rat superior cervical ganglia
(Vartian et al., 2001
). After
separation by agarose gel electrophoresis and blotting, the extracted RNA was
analyzed with probes specific for P2Y1, P2Y2,
P2Y4, and P2Y6. As shown in
Figure 2C,
considerable amounts of RNA coding for P2Y2, but none for
P2Y1, P2Y4 (data not shown), or P2Y6, were
detected in nondifferentiated PC12 cells. RNA isolated from primary cultures
of rat superior cervical ganglia gave positive signals for P2Y1,
P2Y2, and P2Y6 (Fig.
2C), but not for P2Y4 (data not shown).
Previously, transcripts for P2Y4 and P2Y6 receptors, but
none for P2Y1 receptors, had been detected in PC12 cells by RT-PCR
(Arslan et al., 2000
;
Unterberger et al., 2002
).
Thus, nondifferentiated PC12 cells express high levels of P2Y2, but
of no other phospholipase C-linked P2Y receptor.
After differentiation of PC12 cells with recombinant human
-nerve
growth factor (50 ng/ml for 5 d), P2Y2 receptor-specific RNA was
slightly decreased, and the expression of P2Y6 receptors was
induced (Fig. 2C). In
parallel, the UTP-dependent IP1 accumulation was reduced in nerve
growth factor-treated cells as compared with nontreated PC12 cells, and the
P2Y6 receptor agonist UDP still failed to significantly alter
IP1 (Fig.
2D). This corroborates that the P2Y2 but no
other P2Y receptor subtype mediates the nucleotide-dependent IP1
accumulation in PC12 cells.
Autocrine-paracrine activation of endogenous P2Y2
receptors
In non-neural cells, such as Madin-Darby canine kidney cells, endogenous
P2Y receptors were found to be activated by endogenous nucleotides released,
for instance, in response to the exchange of culture media
(Ostrom et al., 2000
). To
reveal whether endogenous P2Y receptors of PC12 cells may become activated
under the present experimental conditions even in the absence of added
nucleotides, cultures were incubated in LiCl (10 mM) in the
presence of apyrase (1 U/ml); however, the degradation of nucleotides by
apyrase did not alter the values of basal IP1 accumulation,
although the enzyme did abolish the IP1-stimulating effect of 10
µM ATP (Fig. 3).
To certify that this inhibitory action of apyrase was not caused by some
unspecific effect on IP accumulation or phospholipase C activity, the enzyme
was also used together with bradykinin; however, apyrase left the IP synthesis
in the presence of this peptide unchanged
(Fig. 3). Depolarization of
PC12 cells by 100 mM K+ enhanced the IP1
accumulation twofold, i.e., to almost the same extent as the exogenous
application of 10 µM ATP. This effect of depolarizing
K+ concentrations was abolished in the presence of apyrase, which
indicates that it was caused by the release of endogenous nucleotides. In
addition, the effect was also attenuated in the presence of 1 mM
Cd2+ (Fig.
3), which prevents Ca2+ entry via
voltage-gated Ca2+ channels and thereby suppresses
depolarization-evoked transmitter release
(Boehm, 1999
). Thus, the
stimulation of IP1 synthesis by endogenously released nucleotides
required depolarization-evoked release.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 3. Stimulation of IP synthesis by released nucleotides. After loading with
myo-[3H]inositol and preincubation in LiCl (10 mM), the
cells were incubated for 30 min in LiCl alone or LiCl plus the indicated
concentrations of apyrase, ATP, bradykinin (Bk), KCl (NaCl was reduced
accordingly), or CdCl2. The amount of radioactivity retrieved
within the fraction of inositol monophosphate (IP1) was calculated
as percentage of the total water-soluble radioactivity extracted from the cell
cultures, and values obtained in the presence of the above agents were
normalized to the data obtained in their absence (normalized to basal);
n = 5-14. **p < 0.01 versus the value obtained
in the presence of LiCl only; ++p < 0.01 versus the
value obtained in the presence of LiCl plus ATP; ##p <
0.01 versus the value obtained in the presence of LiCl plus 100 mM
K+. In the presence of LiCl only, 2968.6 ± 200.5 cpm were
retrieved in the IP1 fraction (n = 16).
|
|
Autocrine-paracrine activation of endogenous P2Y12
receptors
Apart from P2Y2 receptors, as shown above, PC12 cells express
another endogenous P2Y receptor: this is a P2Y12 receptor,
activation of which causes an inhibition of adenylyl cyclase
(Unterberger et al., 2002
). In
contrast to P2Y2 receptors, P2Y12 receptors are
activated by ADP rather than ATP
(Hollopeter et al., 2001
). To
investigate whether this latter receptor might show a different pattern of
activation, we measured the formation of cAMP under various conditions. After
labeling of PC12 cells with [3H]adenine, 339.7 ± 23.3 cpm
(n = 23) were retrieved within the fraction of cAMP, which
corresponded to 0.060 ± 0.007% of the total radioactivity extracted
from the cultures. These and all subsequent values were obtained in the
presence of the phosphodiesterase inhibitor RO 20-1724 (100 µM).
Therefore, any drug-induced alteration will reflect changes in adenylyl
cyclase activity rather than alterations in cAMP degradation
(Unterberger et al., 2002
).
Exposure of PC12 cells to 1 µM of the A2A adenosine
receptor agonist CGS 21680 for 15 min increased cellular cAMP by
20-fold
(Fig. 4A). In the
presence of 10 µM ADP, this CGS 21680-induced accumulation of
cAMP was markedly reduced. The P2Y12 receptor antagonist 2-MeSAMP
(10-100 µM) (Hollopeter et
al., 2001
) abolished this inhibitory effect of ADP
(Fig. 4C). This
corroborates previous results indicating that P2Y12 receptors
mediate an inhibition of adenylyl cyclase in PC12 cells
(Kubista et al., 2003
).

View larger version (18K):
[in this window]
[in a new window]
|
Figure 4. Inhibition of cAMP synthesis by added and released nucleotides. After
loading with [3H]adenine, PC12 cells were incubated in RO 20-1724
(100 µM) for 105 min. During the last 15 min of this incubation
period, 1 µM CGS 21680 was present either alone or together with
the indicated concentrations of additional agents. The amount of radioactivity
retrieved within the fraction of cAMP was calculated as percentage of the
total radioactivity extracted from the cell cultures, and values obtained in
the presence of CGS 21680 were normalized to the data obtained in its absence
(normalized to basal). A, Cells were incubated in the presence (open
bar) or absence (filled bar) of 1 µM CGS 21680; n = 41.
B, Cells were incubated in the presence of the indicated
concentrations (micromolar) of CGS 21680 or 2MeSAMP, or both; n =
6-9; ** p < 0.01 versus the value obtained in the
presence of CGS 21680 only. C, Cells were incubated in the presence
of the indicated concentrations (micromolar) of CGS 21680 and ADP or 2MeSAMP,
or both; n=6-9; ***p < 0.001 versus the value
obtained in the presence of CGS 21680 only; n.s. indicates no significant
difference. D, Cells were incubated in the presence of the indicated
concentrations of CGS 21680, apyrase, and KCl (NaCl was reduced accordingly)
or CdCl2, or both; n = 6-9; **p <
0.01 and ***p < 0.001, respectively, versus the value
obtained in the presence of CGS 21680 only; n.s. indicates no significant
difference.
|
|
When 10 or 100 µM 2-MeSAMP was applied together with CGS
21680, but in the absence of ADP, the stimulation of cAMP synthesis by the
A2A receptor agonist was enhanced significantly
(Fig. 4B).
Furthermore, application of apyrase (1 U/ml) together with CGS 21680 caused a
similar increase in cAMP accumulation as the P2Y12 receptor
antagonist (Fig. 4D).
Thus, there was a spontaneous activation of the P2Y receptor that is
negatively linked to adenylyl cyclase. When PC12 cells were depolarized by 100
mM K+, the CGS 21680-induced cAMP accumulation was
reduced to approximately the same extent as by 10 µM ADP. This
inhibition attributable to K+ depolarization was attenuated by the
addition of apyrase and thus was mediated by released nucleotides. Finally,
the inhibitory effect of 100 mM K+ was prevented by 1
mM Cd2+
(Fig. 4D), which
indicates a role of Ca2+-dependent vesicle exocytosis.
Cd2+ (1 mM) per se did not alter the CGS
21680-induced cAMP accumulation. Taken together, these results suggest that
P2Y12 receptors endogenously expressed in PC12 cells are activated
to some extent by spontaneously released nucleotides and can be activated
further by nucleotides released by K+ depolarization.
Autocrine-paracrine activation of overexpressed P2Y2
receptors
One of the reasons for the lack of spontaneous P2Y2 receptor
activation as opposed to the spontaneous activation of P2Y12
receptors might be a low number of endogenously expressed P2Y2
receptors. Therefore, PC12 cell clones stably overexpressing rat
P2Y2 receptors (PC12-P2Y2) were generated, and three
clones (clones 12, 14, and 17) were tested for their capability to synthesize
IP1 in the absence and presence of UTP. As shown in
Figure 5A, in clones
12 and 17, the spontaneous accumulation of IP1 was not different
from that in wild-type PC12 cells, whereas in clone 14 it was enhanced by a
factor of 3.5. In these three clones, the increases in IP1
synthesis caused by 10 µM UTP were 6.3 ± 0.5 (clone 12),
6.9 ± 0.8 (clone 14), and 8.9 ± 0.6 (clone 17)-fold,
respectively. In wild-type PC12 cells, in contrast, this UTP-induced increase
was only 2.2 ± 0.15-fold (Fig.
5A). Thus, overexpression increased the efficacy of the
agonists. In addition, in clone 14 of PC12-P2Y2 cells, not only the
efficacies but also the potencies of both ATP and UTP to stimulate
IP1 synthesis were enhanced as compared with wild-type PC12 cells;
half-maximal effects were observed at 1.4 ± 0.1 µM (ATP)
and 1.6 ± 0.4 µM(UTP), respectively, and the maximum was
a ninefold stimulation over basal (Fig.
5B).

View larger version (15K):
[in this window]
[in a new window]
|
Figure 5. Stimulation of IP synthesis in P2Y2 receptor-overexpressing
cells. After loading with myo-[3H]inositol and preincubation in
LiCl (10 mM), the cells were incubated for 30 min in LiCl alone or
LiCl plus the indicated concentrations of apyrase, ATP, UTP, KCl (NaCl was
reduced accordingly), or CdCl2. The amount of radioactivity
retrieved within the fraction of inositol monophosphate (IP1) was
calculated as percentage of the total water-soluble radioactivity extracted
from the cell cultures (A), and values obtained in the presence of
the above agents were normalized to the data obtained in their absence
(normalized to basal) (B, C). A, Either wild-type PC12 cells
or three clones (clones 12, 14, or 17) of P2Y2
receptor-overexpressing cells were exposed to LiCl (open bars) or to LiCl plus
10 µM UTP (filled bars); n = 6; **p
< 0.01 for the difference between the value obtained in the presence LiCl
in P2Y2 receptor-overexpressing cells versus the value in wild-type
cells; n.s. indicates no significant difference. B,
PC12-P2Y2 cells of clone 14 were exposed to the indicated
concentrations of ATP or UTP; n = 6-9. C,
PC12-P2Y2 cells of clone 14 were exposed to the indicated
concentrations of one or more of the following: ATP, apyrase, KCl, and
CdCl2; n = 6-9; ***p < 0.001 versus
the value obtained in the presence of LiCl only; ++p <
0.01 versus the value obtained in the presence of LiCl plus ATP;
##p < 0.01 and ###p < 0.001
versus the value obtained in the presence of LiCl plus KCl. In the absence of
nucleotides or other agents, 2210.0 ± 92.1 cpm were retrieved in the
IP1 fraction of wild-type PC12 cells (n = 6), 1595.7
± 62.4 cpm in clone 12 (n = 6; p < 0.01 vs wild
type), 5143.6 ± 390.1 in clone 14 (n = 24; p <
0.001 vs wild type), and 2744.5 ± 226.9 cpm in clone 17 (n =
6; p > 0.1 vs wild type).
|
|
The above results reveal that in PC12-P2Y2 cells, the ability of
P2Y2 receptors to mediate nucleotide-dependent IP1
synthesis was markedly enhanced. To evaluate whether overexpressed
P2Y2 receptors might become activated by spontaneously released
nucleotides, we further used clone 14, which displayed the highest levels of
spontaneous as well as UTP-dependent IP1 synthesis
(Fig. 5A).
Nevertheless, apyrase (1 U/ml) failed to significantly reduce the accumulation
of IP1 in the absence of exogenous nucleotides, although the enzyme
did reduce the stimulating effect of ATP. Depolarization of
PC12-P2Y2 cells by 100 mM K+ enhanced the
IP1 accumulation to almost the same extent as 10 µM
ATP (Fig. 5C), as
described above for untransfected PC12 cells
(Fig. 3). Again, in
PC12-P2Y2 cells the IP1-increasing action of 100
mM K+ was abolished in the presence of apyrase and by
the Ca2+ channel blockade by Cd2+
(Fig. 5C), as it was
in untransfected PC12 cells. Thus, overexpression of P2Y2 receptors
was not sufficient to allow for a stimulation of IP1 synthesis by
released nucleotides in the absence of depolarizing stimuli.
Autocrine-paracrine activation of heterologously expressed
P2Y1 receptors
P2Y2 receptors are equipotently activated by ATP and UTP, but
they are insensitive to nucleoside diphosphates
(Nicholas et al., 1996
).
P2Y12 receptors, in contrast, are potently activated by ADP
(Hollopeter et al., 2001
). To
learn whether another P2Y receptor that accepts diphosphates as agonists might
also be activated by spontaneously released nucleotides, PC12 cell lines
permanently expressing rat P2Y1 receptors linked to eGFP
(PC12-P2Y1) were generated. Previously, this fusion protein was
found to mediate a stimulation of IP synthesis about as efficiently as
nontagged rat P2Y1 receptors
(Vohringer et al., 2000
). In
the three PC12-P2Y1 clones that were tested for IP1
accumulation (clones 4, 5, and 8), its synthesis in the absence of added
nucleotides was increased by factors of up to 45. Addition of 1
µM of the P2Y1 receptor antagonist MRS 2216
(Nandanan et al., 1999
)
significantly reduced these values of spontaneous IP1 accumulation
in these three PC12-P2Y1 clones but had no effect in untransfected
PC12 cells (Fig. 6A).
This action of MRS 2216 was concentration dependent, with half-maximal effects
at 0.37 ± 0.13 µM
(Fig. 6B). This value
is in reasonable agreement with the half-maximal concentrations of MRS 2216
(0.2 µM) required to antagonize the stimulation of IP synthesis
via P2Y1 receptors in turkey erythrocytes
(Nandanan et al., 1999
).
Addition of apyrase (1 U/ml) also reduced the spontaneous accumulation of
IP1 in the three PC12-P2Y1 clones tested by 75% to
>90% (Fig. 6C).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 6. Stimulation of IP synthesis in P2Y1 receptor-expressing cells.
After loading with myo-[3H]inositol and preincubation in LiCl (10
mM), the cells were incubated for 30 min in LiCl alone or LiCl plus
the indicated concentrations of MRS 2216, apyrase, 2-methylthio ATP (2MeSATP),
KCl (NaCl was reduced accordingly), or CdCl2. The amount of
radioactivity retrieved within the fraction of inositol monophosphate
(IP1) was calculated as percentage of the total water-soluble
radioactivity extracted from the cell cultures (A), and values
obtained in the presence of the above agents were normalized to the data
obtained in their absence (normalized to basal) (B[en]D).
A, Either wild-type PC12 cells or three clones (clones 4, 5, and 8)
of P2Y1 receptor-expressing cells were exposed to LiCl (open bars)
or LiCl plus 1 µM MRS 2216 (filled bars); n = 6-12. The
p values shown above the bars are related to the differences between
the values obtained in the presence of LiCl in the P2Y1
receptor-expressing cells versus the same value in wild-type PC12 cells;
*p < 0.05, **p < 0.01, and
***p < 0.001 versus the value obtained in the absence
of MRS 2216, respectively. B, PC12-P2Y1 cells of clone 5
were incubated in the indicated concentrations of MRS 2216; n = 4-6.
C, Three clones (clones 4, 5, and 8) of P2Y1
receptor-expressing cells were exposed to LiCl (open bars) or LiCl plus
apyrase (filled bars); n = 6-12; **p < 0.01
and ***p < 0.001 versus the value obtained in the
absence of apyrase, respectively. D, Two clones (clones 5 and 8) of
P2Y1 receptor-expressing cells were exposed to the indicated
concentrations of one or more of the following: 2MeSATP, apyrase, KCl, and
CdCl2; n = 6-12; ***p < 0.001
versus the value obtained in the presence of LiCl only; n.s. indicates no
significant difference. In the absence of nucleotides or other agents, 3178.6
± 153.6 cpm were retrieved in the IP1 fraction of wild-type
PC12 cells (n = 6), 119973.8 ± 9125.1 cpm in clone 4
(n = 9; p < 0.001 vs wild type), 306452.8 ±
25304.4 in clone 5 (n = 24; p < 0.001 vs wild type), and
13004.3 ± 1974.7 cpm in clone 8 (n = 15; p < 0.001
vs wild type).
|
|
The data shown above indicate that the P2Y1 receptors were
highly activated under our routine experimental conditions. This conclusion is
supported further by the fact that addition of 2MeSATP (10 µM),
which potently activates the P2Y1-eGFP fusion protein in human
embryonic kidney (HEK) 293 cells
(Vohringer et al., 2000
),
either failed to significantly enhance IP1 accumulation or caused
an increase by only 13 ± 3% (Fig.
6D). In untransfected PC12 cells, for comparison, this
P2Y1 agonist also failed to cause significant changes in
IP1 synthesis (Fig.
1B). Depolarization of PC12-P2Y1 cells by 100
mM K+ did not enhance the accumulation of
IP1, nor did the concomitant application of 1 mM
Cd2+ cause any further change. In the presence of 100
mM K+ plus 1 U/ml apyrase, the IP1 values
obtained with PC12-P2Y1 cells were significantly lower than those
obtained under control conditions and about the same as those obtained in the
presence of apyrase only (Fig.
6D). Thus, P2Y1 receptors heterologously
expressed in PC12 cells are spontaneously activated to an extent that renders
further activation by either exogenously added or endogenously released
nucleotides virtually impossible.
Activation of heterologously expressed P2Y1 receptors by
added nucleotides
From the data presented above it was not possible to estimate at which
nucleotide concentrations the P2Y1-GFP receptors were activated
when expressed in PC12 cells. To be able to do so, we searched for a measure
of receptor activation that could be determined in the absence of released
nucleotides. Single PC12 cells can be investigated by electrophysiological
recording techniques under continuous superfusion to remove released
nucleotides (Vartian and Boehm,
2001
). P2Y1 receptors, when expressed in rat superior
cervical ganglion neurons, mediate an inhibition of KM
channels in the presence of nanomolar ADP concentrations
(Brown et al., 2000
). We
therefore hypothesized that this effect might also be seen in PC12 cells and
determined IM under continuous superfusion. In wild-type
PC12 cells, ADP failed to cause significant changes in IP1
accumulation (Fig. 1B)
and left IM amplitudes unchanged
(Fig. 7A). In
PC12-P2Y1 cells, however, ADP reduced IM in
a

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7. Inhibition of IM in P2Y1 receptor expressing
cells. A, IM was measured by the amphotericin B-perforated
patch technique in a wild-type PC12 cell and in a PC12 cell stably expressing
P2Y1 receptors (PC12-P2Y1). The current traces shown
were obtained by clamping the cell at -30 mV and by applying 1 sec
hyperpolarizing voltage steps to -55 mV; the recordings were performed before
(control), during, and after (washout) the application of the indicated
concentrations of ADP. B, Four to six PC12-P2Y1 cells were
exposed to the indicated concentrations of ADP, and the graph shows the
concentration dependence of the inhibition of IM
relaxation amplitudes, determined as shown in A.
|
|
 |
Discussion
|
|---|
P2X receptors mediate neurotransmission when ATP is released by presynaptic
action potentials (Robertson et al.,
2001
). In contrast, the mechanisms of activation and the functions
of neuronal P2Y receptors are essentially unknown
(Boehm, 2003
). When P2Y
receptors are heterologously expressed in neurons, their activation leads to
an inhibition of KM and voltage-gated
Ca2+ channels (Simon
et al., 2002
; Filippov et al.,
2003
). Evidence has been presented that depolarization of
chromaffin cells leads to an autocrine-paracrine inhibition of
Ca2+ channels via opioid and P2Y receptors
(Currie and Fox, 1996
). In
non-neural cells, in contrast, the autocrine-paracrine activation of P2Y
receptors does not require depolarizing stimuli, and a simple exchange of
culture media was found sufficient
(Lazarowski et al., 2000
;
Ostrom et al., 2000
). By using
PC12 cells, the present results reveal that neuronal P2Y receptors are
differentially activated by spontaneous and depolarization-evoked nucleotide
release.
The accumulation of IPs and the inhibition of cAMP synthesis in the
presence of added nucleotides revealed that PC12 cells express two types of
functional P2Y receptors. The one coupled to IP synthesis is a P2Y2
receptor as revealed by the following results: (1) it was equipotently
activated by ATP and UTP and thus could be P2Y2 or P2Y4
(Kennedy et al., 2000
); (2)
P2Y2 receptors are expressed at higher levels than P2Y4;
(3) the receptor was blocked by suramin but not by PPADS, and the reverse is
true for P2Y4 (Bogdanov et al.,
1998
; Suarez-Huerta et al.,
2001
); (4) differentiation of PC12 cells reduced the expression of
P2Y2 and diminished the IP synthesis in response to UTP. The
reduction of cAMP, in contrast, is induced by ADP and ATP, but not UDP or UTP,
and is antagonized by the P2Y12 antagonists 2MeSAMP and AR-C69931MX
(Unterberger et al., 2002
;
Kubista et al., 2003
), thus
indicating a role of this latter receptor.
Degradation of nucleotides by apyrase did not alter IP accumulation in the
absence of added nucleotides but enhanced the cAMP synthesis triggered by
A2A receptor activation. Thus, P2Y12 but not
P2Y2 receptors were activated spontaneously. Depolarization of PC12
cells further decreased the cAMP synthesis and increased the IP accumulation.
Both effects were abolished by apyrase and by the blockade of voltage-gated
Ca2+ channels by Cd2+. Hence, both
types of P2Y receptors expressed in PC12 cells can be activated by
depolarization-evoked nucleotide release.
One reason for the differential sensitivities for endogenously released
nucleotides could be differences in agonist potencies of nucleotides at the
receptors involved; however, overexpression of P2Y2 receptors did
not allow for spontaneous receptor activation, although the potencies and
efficacies of added nucleotides to induce IP synthesis were increased. In
contrast, the heterologous expression of P2Y1 receptors led to huge
increases in spontaneous IP accumulation, which was hardly enhanced by added
nucleotides or depolarization of the cells, but mostly reduced by apyrase or a
P2Y1 receptor antagonist. Nevertheless, these P2Y1
receptors could be activated by adding ADP when released nucleotides were
removed by continuous superfusion. Furthermore, similar concentrations of
added nucleotides were required to cause half-maximal activation of
overexpressed P2Y2 receptors (1.4 µM ATP) and
heterologously expressed P2Y1 receptors (1.9 µM ADP).
Thus, there were no significant differences in the potencies of agonistic
nucleotides at these two receptors expressed in PC12 cells. One major
difference between P2Y1 and P2Y2 receptors is their
distinct nucleotide sensitivity: P2Y1 but not P2Y2
receptors are activated not only by ATP but also by ADP
(Ralevic and Burnstock, 1998
).
P2Y12 receptors also accept ADP as an agonist
(Hollopeter et al., 2001
).
Hence, the propensity of recombinant P2Y1 and native
P2Y12 receptors to be activated by spontaneous nucleotide release
is related to their sensitivity for nucleoside diphosphates rather than to
higher receptor densities or higher nucleotide potencies.
This leads to the question of species and quantities of nucleotides
released from PC12 cells. Large and small dense-core vesicles contain
millimolar concentrations of adenine nucleotides. Among these, one can find
ATP, ADP, and AMP at a 1:0.14:0.04 ratio
(Zimmermann, 1994
). Therefore,
the main nucleotide released from PC12 cells is ATP. We did not try to
determine concentrations of ATP or ADP in the culture medium, because
concentrations of nucleotides in solutions in which cells under investigation
are incubated do not reflect the concentrations close to the plasma membrane,
where receptors are activated (Beigi et
al., 1999
). Nevertheless, our results with endogenous and
overexpressed P2Y2 receptors provide an indication of the
periplasmalemmal ATP concentration yielded by K+ depolarization:
100 mM K+ stimulated IP synthesis somewhat less than 10
µM but definitely more than 1 µM ATP. Similarly,
the K+ depolarization reduced cAMP accumulation to almost the same
extent as 10 µM ADP, which is equipotent and equi-effective to
ATP in inhibiting adenylyl cyclase in PC12 cells
(Unterberger et al., 2002
).
Therefore, the concentration of endogenous ATP surrounding PC12 cells during
K+ depolarization must be in the low micromolar range. This
estimate is similar to the concentration of ATP surrounding platelets when
stimulated by thrombin, which lies between 5 and 20 µM
(Beigi et al., 1999
). Because
neither endogenous nor overexpressed P2Y2 receptors were activated
under basal conditions, the periplasmalemmal ATP concentration in the absence
of depolarizing stimuli must be below the 100 nM of added ATP that
was required to cause minimal stimulation of IP synthesis
(Fig. 5B).
In contrast to P2Y2 receptors, endogenous P2Y12 and
recombinant P2Y1 receptors were activated spontaneously. At rat
P2Y12 receptors, ADP is 10-fold more potent than ATP
(Simon et al., 2002
), and at
the rat P2Y1-GFP fusion protein, ADP is 100-fold more potent than
ATP (Vohringer et al., 2000
).
Thus, the spontaneous activation of P2Y12 and P2Y1
receptors was mediated by ADP rather than ATP. The spontaneous activation of
P2Y12 receptors limited the stimulation of cAMP synthesis by the
A2A receptor agonist CGS 21680. In the absence of added
nucleotides, CGS 21680 enhanced cAMP accumulation 20-fold; in the presence of
apyrase or the P2Y12 antagonist 2MeSAMP, however, this stimulation
was increased to
50-fold, and added ADP reduced this stimulation down to
5-fold over basal. Thus, the value obtained in the absence of agonists and
antagonists was close to the arithmetic mean of these two extremes, which
indicates that the receptors were approximately half-activated. In rat
endothelial cells, inhibition of adenylyl cyclase via P2Y12
receptors is half-maximal at 3 µM ADP
(Simon et al., 2002
).
P2Y1-GFP receptors were completely activated under conditions of
spontaneous nucleotide release. When released nucleotides were removed by
superfusion, the P2Y1-GFP receptor was activated at 1-10
µM ADP, as determined by the inhibition of
IM. In HEK 293 cells expressing the P2Y1-GFP
receptor,
1 µM ADP causes maximal IP accumulation
(Vohringer et al., 2000
).
Taken together, the above considerations suggest that the basal
periplasmalemmal ADP concentration in PC12 cell cultures was in the range of
1-10 µM.
These data indicate that in PC12 cell cultures, ADP concentrations are
higher than those of ATP, although more ATP is released
(Zimmermann, 1994
). The
explanation for this discrepancy is the fact that PC12 cells express
ectonucleotidases that degrade ATP four times more rapidly than ADP. As a
consequence, extracellular ADP accumulates
(Vollmayer et al., 2001
), and
this is the basis for the spontaneous activation of nucleoside
diphosphate-sensitive (P2Y12 and P2Y1) receptors and the
lack of spontaneous activity of (P2Y2) receptors that are sensitive
only to nucleoside triphosphates. Nevertheless, these latter receptors become
activated when the release of ATP is increased by K+ depolarization
and exceeds its degradation to ADP. Thus, the endowment of PC12 cells with
ectonucleotidases and P2Y receptors provides specific sensors for spontaneous
and stimulation-evoked vesicle exocytosis. Accordingly, in PC12 cells, levels
of second messengers linked to P2Y receptors will correlate with the
electrical activity of the cells.
The present as well as previous results show that in a given cell, the
autocrine-paracrine regulation via released nucleotides depends on the
presence of both P2Y receptors and nucleotidases. In hepatoma cells
(Junankar et al., 2002
), for
example, released ATP is degraded to ADP to stimulate P2Y1
receptors. In epithelial (Torres et al.,
2002
) and osteoblastic (You et
al., 2002
) cells, in contrast, released ATP itself activates
P2Y11 and P2Y2 receptors, respectively. In PC12 cells,
both types of autocrine-paracrine regulation occur under resting conditions
and during depolarization and involve P2Y12 and P2Y2
receptors, respectively. In sympathetic neurons that are ontogenetically
related to PC12 cells, nucleotide release occurs at a low rate that is mostly
enhanced by depolarization (von Kugelgen
et al., 1994
). Together with nucleotides, sympathetic neurons
release soluble nucleotidases that degrade ATP twice as rapidly as ADP
(Mihaylova-Todorova et al.,
2002
), and therefore ADP accumulates rather than ATP
(Todorov et al., 1997
).
Because sympathetic neurons, like PC12 cells, express several P2Y receptors
linked to different signaling cascades
(Fig. 2C), the
phenomena described above for PC12 cells can be expected to apply to the
sympathetic and possibly to other pathways within the nervous system.
 |
Footnotes
|
|---|
Received Feb. 27, 2003;
revised Jun. 13, 2003;
accepted Jun. 16, 2003.
This work was supported by European Commission Grant QLRT-2000-00929 and by
grants from the Austrian Science Fund (Fonds zur Foerderung der
Wissenschaftlichen Forschung; P14951
[GenBank]
and P15797
[GenBank]
) and from the Virologie Fonds
of the Medical Faculty of the University of Vienna. We are indebted to Dr. M.
Freissmuth for carefully reading this manuscript.
Correspondence should be addressed to Stefan Boehm, Institute of
Pharmacology, University of Vienna, Waehringerstrasse 13a, A-1090 Vienna,
Austria. E-mail:
stefan.boehm{at}univie.ac.at.
Copyright © 2003 Society for Neuroscience
0270-6474/03/237479-10$15.00/0
 |
References
|
|---|
Arslan G, Filipeanu CM, Irenius E, Kull B, Clementi E, Allgaier C,
Erlinge D, Fredholm BB (2000) P2Y receptors contribute to
ATP-induced increases in intracellular calcium in differentiated but not
undifferentiated PC12 cells. Neuropharmacology
39: 482-496.[Web of Science][Medline]
Beigi R, Kobatake E, Aizawa M, Dubyak GR (1999)
Detection of local ATP release from activated platelets using cell
surface-attached firefly luciferase. Am J Physiol
276: C267-C278.
Boehm S (1999) ATP stimulates sympathetic transmitter
release via presynaptic P2X purinoceptors. J Neurosci
19: 737-746.[Abstract/Free Full Text]
Boehm S (2003) P2Ys go neuronal: modulation of
Ca2+ and K+ channels by recombinant
receptors. Br J Pharmacol 138:
1-3.[Web of Science][Medline]
Bofill-Cardona E, Vartian N, Nanoff C, Freissmuth M, Boehm S
(2000) Two different signaling mechanisms involved in the
excitation of rat sympathetic neurons by uridine nucleotides. Mol
Pharmacol 57:
1165-1172.[Abstract/Free Full Text]
Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G
(1998) Molecular cloning and characterization of rat P2Y4
nucleotide receptor. Br J Pharmacol 124:
428-430.[Web of Science][Medline]
Brown DA, Filippov AK, Barnard EA (2000) Inhibition of
potassium and calcium currents in neurones by molecularly-defined P2Y
receptors. J Auton Nerv Syst 81:
31-36.[Web of Science][Medline]
Communi D, Pirotton S, Parmentier M, Boeynaems JM
(1995) Cloning and functional expression of a human uridine
nucleotide receptor. J Biol Chem 270:
30849-30852.[Abstract/Free Full Text]
Communi D, Govaerts C, Parmentier M, Boeynaems JM
(1997) Cloning of a human purinergic receptor coupled to
phospholipase C and adenylyl cyclase. J Biol Chem
51: 31969-31973.
Communi D, Gonzales NS, Detheux M, Brezillon S, Lannoy V,
Parmentier M, Boeynaems JM (2001) Identification of a novel human
ADP receptor coupled to Gi. J Biol Chem
276: 41479-41485.[Abstract/Free Full Text]
Currie KPM, Fox AP (1996) ATP serves as a negative
feedback inhibitor of voltage-gated Ca2+ channel
currents in bovine adrenal chromaffin cells. Neuron
16: 1027-1036.[Web of Science][Medline]
De Lean A, Munson PJ, Rodbard D (1978) Simultaneous
analysis of families of sigmoidal curves: application to bioassay, radioligand
assay, and physiological dose-response curves. Am J Physiol
235: 97-102.
Filippov AK, Simon J, Barnard EA, Brown DA (2003)
Coupling of the nucleotide P2Y4 receptor to neuronal ion channels.
Br J Pharmacol 138:
400-406.[Web of Science][Medline]
Fisher RJ, Burgoyne RD (1999) The effect of
transfection with Botukinum neurotoxin C1 light chain on exocytosis measured
in cell populations and by single-cell amperometry in PC12 cells.
Pflügers Arch 437:
754-762.[Web of Science][Medline]
Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC,
Stenmark KR (2002) Extracellular ATP is an autocrine-paracrine
regulator of hypoxia-induced adventitial fibroblast growth. J Biol
Chem 277:
44638-44650.[Abstract/Free Full Text]
Greene LA, Tischler AS (1976) Establishment of a
noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond
to nerve growth factor. Proc Natl Acad Sci USA
73: 2424-2428.[Abstract/Free Full Text]
Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan
V, Yang RB, Nurden A, Julius D, Conley PB (2001) Identification
of the plateleted ADP receptor targeted by antithrombotic drugs.
Nature 409:
202-207.[Medline]
Junankar PR, Karjalainen A, Kirk K (2002) The role of
P2Y1 purinergic receptors and cytosolic Ca2+ in
hypotonically activated osmolyte efflux from a rat hepatoma cell line.
J Biol Chem 277:
40324-40334.[Abstract/Free Full Text]
Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA
(2000) ATP, an agonist at the rat P2Y(4) receptor, is an
antagonist at the human P2Y4 receptor. Mol Pharmacol
57: 926-931.[Abstract/Free Full Text]
Kubista H, Lechner SG, Wolf AM, Boehm S (2003)
Attenuation of the P2Y receptor-mediated control of neuronal
Ca2+ channels in PC12 cell by antithrombotic drugs.
Br J Pharmacol 138:
343-350.[Web of Science][Medline]
Lazarowski ER, Boucher RC, Harden TK (2000)
Constitutive release of ATP and evidence for major contribution of
ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to
extracellular nucleotide concentrations. J Biol Chem
275: 31061-31068.[Abstract/Free Full Text]
Lustig KD, Shiau AK, Brake AJ, Julius D (1993)
Expression cloning of an ATP receptor from mouse neuroblastoma cells.
Proc Natl Acad Sci USA 90:
5113-5117.[Abstract/Free Full Text]
Matthews G (1996) Transmitter release. Annu Rev
Neurosci 19:
219-233.[Web of Science][Medline]
Mihaylova-Todorova ST, Todorov LD, Westfall DP (2002)
Enzyme kinetics and pharmacological characterization of nucleotidases released
from the guinea pig isolated vas deferens during nerve stimulation: evidence
for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and
a soluble ecto-5'-nucleotidase-like AMPase. J Pharmacol Exp
Ther 302:
992-1001.[Abstract/Free Full Text]
Murrin JA, Boarder MR (1992) Neuronal nucleotide
receptor linked to phospholipase C and phospholipase D? Stimulation of PC12
cells by ATP analogues and UTP. Mol Pharmacol
41: 561-568.[Abstract]
Nandanan E, Camaioni E, Jang SY, Kim YC, Cristalli G, Herdewijn P,
Secrist JA, Tiwari KN, Mohanram A, Harden TK, Boyer JL, Jacobson KA
(1999) Structure-activity relationships of biphosphate nucleotide
derivatives as P2Y1 receptor antagonists and partial agonists.
J Med Chem 42:
1625-1638.[Medline]
Nicholas RA, Watt WC, Lazarowski ER, Li Q, Harden TK
(1996) Uridine nucleotide selectivity of three phospholipase
C-activating P2 receptors: identification of a UDP-selective, a UTP-selective,
and an ATP- and UTP-specific receptor. Mol Pharmacol
50: 224-229.[Abstract]
Ostrom RS, Gregorian C, Insel PA (2000) Cellular
release of and response to ATP as key determinants of the set-point of signal
transduction pathways. J Biol Chem 275:
11735-11739.[Abstract/Free Full Text]
Phiel CJ, Klein PS (2001) Molecular targets of lithium
action. Annu Rev Pharmacol Toxicol 41:
789-813.[Web of Science][Medline]
Ralevic V, Burnstock G (1998) Receptors for purines
and pyrimidines. Pharmacol Rev 50:
413-492.[Abstract/Free Full Text]
Robertson SJ, Ennion SJ, Evans RJ, Edwards FA (2001)
Synaptic P2X receptors. Curr Opin Neurobiol
11: 378-386.[Web of Science][Medline]
Schlosser SF, Burgstahler AD, Nathanson MH (1996)
Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells
by release of nucleotides. Proc Natl Acad Sci USA
93: 9948-9953.[Abstract/Free Full Text]
Scholze T, Moskvina E, Mayer M, Just H, Kubista H, Boehm S
(2002) Sympathoexcitation by bradykinin involves
Ca2+-independent protein kinase C. J
Neurosci 22:
5823-5832.[Abstract/Free Full Text]
Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J,
Hanaoka K, Guggino WB, Guay-Woodford LM, Bell BD, Suillivan LP, Grantham JJ,
Taylor AL (2002) Autocrine extracellular purinergic signaling in
epithelial cells derived from polycystic kidneys. Am J Physiol
282: F763-F775.
Simon J, Filippov AK, Goransson S, Wong YH, Frelin C, Michel AD,
Brown DA, Barnard EA (2002) Characterization and channel coupling
of the P2Y12 nucleotide receptor of brain capillary endothelial
cells. J Biol Chem 277:
31390-31400.[Abstract/Free Full Text]
Suarez-Huerta N, Pouillon V, Boeynaems JM, Robaye B
(2001) Molecular cloning and characterization of the mouse P2Y4
receptor. Eur J Pharmacol 416:
197-202.[Web of Science][Medline]
Tokuyama Y, Hara M, Jones EMC, Fan Z, Bell GI (1995)
Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res
Commun 211:
211-218.[Web of Science][Medline]
Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy
C, Bjur RA, Westfall DP (1997) Neuronal release of soluble
nucleotidases and their role in neurotransmitter inactivation.
Nature 387:
76-79.[Medline]
Torres B, Zambon AC, Insel PA (2002) P2Y11
receptors activate adenylyl cyclase and contribute to nucleotide-promoted cAMP
formation in MDCK-D1 cells. J Biol Chem
277: 7761-7765.[Abstract/Free Full Text]
Unterberger U, Moskvina E, Scholze T, Freissmuth M, Boehm S
(2002) Inhibition of adenylyl cyclase by neuronal P2Y receptors.
Br J Pharmacol 135:
673-684.[Web of Science][Medline]
Vartian N, Boehms S (2001) P2Y receptor-mediated
inhibition of voltage-activated Ca2+ currents in PC12
cells. Eur J Neurosci 13:
899-908.[Web of Science][Medline]
Vartian N, Moskvina E, Scholze T, Unterberger U, Allgaier C, Boehm
S (2001) UTP evokes noradrenaline release from rat sympathetic
neurons by activation of protein kinase C. J Neurochem
77: 876-885.[Medline]
Vohringer C, Schafer R, Reiser G (2000) A chimeric rat
brain P2Y1 receptor tagged with green fluorescent protein: high affinity
ligand recognition of adenosine diphosphates and triphosphates and selectivity
identical to that of the wild-type receptor. Biochem Pharmacol
59: 791-800.[Medline]
Vollmayer P, Koch M, Braun N, Heine P, Servos J, Israr E, Kegel B,
Zimmermann H (2001) Multiple ectonucleotidases in PC12 cells:
identification and cellular distribution after heterologous expression.
J Neurochem 78:
1019-1028.[Web of Science][Medline]
von Kugelgen I, Allgaier C, Schobert A, Starke K
(1994) Co-release of noradrenaline and ATP from cultured
sympathetic neurons. Neuroscience 61:
199-202.[Web of Science][Medline]
Wang Y, Roman R, Lidofsky SD, Fitz JG (1996) Autocrine
signaling through ATP release represents a novel mechanism for cell volume
regulation. Proc Natl Acad Sci USA 93:
12020-12025.[Abstract/Free Full Text]
You J, Jacobs CR, Steinberg TH, Donahue HJ (2002) P2Y
purinoceptors are responsible for oscillatory fluid flow-induced intracellular
Ca2+ mobilization in osteoblastic cells. J Biol
Chem 277:
48724-48729.[Abstract/Free Full Text]
Zimmermann H (1994) Signaling via ATP in the nervous
system. Trends Neurosci 17:
420-426.[Web of Science][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
J. Shi, B. Zemaitaitis, and N. A. Muma
Phosphorylation of G{alpha}11 Protein Contributes to Agonist-Induced Desensitization of 5-HT2A Receptor Signaling
Mol. Pharmacol.,
January 1, 2007;
71(1):
303 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Filippov, R. C. Y. Choi, J. Simon, E. A. Barnard, and D. A. Brown
Activation of P2Y1 Nucleotide Receptors Induces Inhibition of the M-Type K+ Current in Rat Hippocampal Pyramidal Neurons
J. Neurosci.,
September 6, 2006;
26(36):
9340 - 9348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gsandtner and M. Freissmuth
A Tail of Two Signals: The C Terminus of the A2A-Adenosine Receptor Recruits Alternative Signaling Pathways
Mol. Pharmacol.,
August 1, 2006;
70(2):
447 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cataldi, V. Lariccia, A. Secondo, G. di Renzo, and L. Annunziato
The Antiepileptic Drug Levetiracetam Decreases the Inositol 1,4,5-Trisphosphate-Dependent [Ca2+]i Increase Induced by ATP and Bradykinin in PC12 Cells
J. Pharmacol. Exp. Ther.,
May 1, 2005;
313(2):
720 - 730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fabbro, A. Skorinkin, M. Grandolfo, A. Nistri, and R. Giniatullin
Quantal release of ATP from clusters of PC12 cells
J. Physiol.,
October 15, 2004;
560(2):
505 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Ennion, A. D. Powell, and E. P. Seward
Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells
Mol. Pharmacol.,
September 1, 2004;
66(3):
601 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|